U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Wednesday.
Shares of Exact Sciences Corporation EXAS fell sharply in today's pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 revenue guidance below estimates.
Exact Sciences reported quarterly GAAP losses of 21 cents per share, which missed the analyst consensus estimate for losses of 20 cents. Quarterly sales of $709 million missed the consensus estimate of $717.66 million.
Exact Sciences shares dipped 27% to $52.20 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Super Micro Computer, Inc. SMCI fell 24.3% to $20.97 in pre-market trading after the company lowered its financial outlook. The company expects to report first-quarter revenue of $5.9 billion to $6 billion, down from its previous guidance range of $6 billion to $7 billion. The company anticipates adjusted earnings of 75 cents to 76 cents per share, versus its previous guidance of 67 cents to 83 cents per share.
- Gevo, Inc. GEVO fell 20.8% to $1.86 in today's pre-market trading.
- Sunnova Energy International Inc. NOVA fell 20.1% to $5.64 in pre-market trading after gaining 8% on Tuesday.
- PACS Group, Inc. PACS shares fell 18.8% to $24.00 in pre-market trading after the company announced postponement of third-quarter results and disclosure on civil investigative demands from the federal government.
- Sunrun Inc. RUN fell 18.6% to $13.76 in pre-market trading after gaining 5% on Tuesday.
- Evotec SE EVO declined 16.8% to $3.81 in pre-market trading following weak quarterly results.
- Oscar Health, Inc. OSCR shares fell 16.8% to $15.25 in pre-market trading.
- First Solar, Inc. FSLR shares fell 14.7% to $184.00 in pre-market trading.
- The AES Corporation AES declined 9.9% to $13.97 in pre-market trading.
- Honda Motor Co., Ltd. HMC shares fell 7.4% to $28.05 in pre-market trading as the company said profits fell around 20% in the first half of the fiscal year.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.